$JNJ Headlines
Post# of 145205
Posted On: 09/23/2014 10:12:20 AM
$JNJ Headlines
Dow industrials take flight, rally to uncharted territory
10:31 a.m. Sept. 19, 2014
- Michael Ashbaugh
7 reasons to be bullish on Microsoft
6:00 a.m. Sept. 18, 2014
- Jeff Reeves
5 pretty amazing facts about Alibaba
9:54 a.m. Sept. 15, 2014
- Tim Mullaney
Here’s what history says about the stock market in September
5:39 a.m. Sept. 2, 2014
- Mark Hulbert
This one stock sector can withstand all the ‘bubble’ talk
6:00 a.m. Aug. 21, 2014
- Jeff Reeves
Timing this market is guaranteed to make you a loser
1:02 p.m. Aug. 8, 2014
- Mark Hulbert
You don’t have to be a mega-mind to get this trade right
7:54 a.m. Aug. 6, 2014
- Jim Lowell
Mega caps with mega recommendations
7:54 a.m. Aug. 6, 2014
- Mark Hulbert
These eight health-care stocks could rise up to 75%
1:48 p.m. Aug. 5, 2014
- Philip van Doorn
J&J to call for voluntary return of morcellators
5:30 p.m. July 30, 2014
- MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’
1:14 p.m. July 22, 2014
- MarketWatch
Johnson & Johnson sets $5 billion share buyback
5:20 p.m. July 21, 2014
- Jim Jelter
Two rules of thumb for dumping your financial adviser
2:36 p.m. July 18, 2014
- Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap
3:04 p.m. July 15, 2014
- blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook
10:55 a.m. July 15, 2014
- blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger
10:40 a.m. July 15, 2014
- Angela Johnson
Newscast: NBA wants to double TV fees
9:59 a.m. July 15, 2014
- MarketWatch
Johnson & Johnson tops forecasts, boosts outlook
7:57 a.m. July 15, 2014
- MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade
7:51 a.m. July 15, 2014
- Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92
7:50 a.m. July 15, 2014
- William L. Watts
Spectrum to Buy P&G's European Pet Ops
46 min ago9:25 a.m. Sept. 23, 2014
- The Wall Street Journal Interactive Edition
Dividends Vs. Capital Appreciation: Wrong Question
10:14 p.m. Sept. 22, 2014
- Seeking Alpha
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
6:20 p.m. Sept. 22, 2014
- Zacks.com
Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
5:45 p.m. Sept. 22, 2014
- Zacks.com
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
4:45 p.m. Sept. 22, 2014
- Zacks.com
3 Stocks Reiterated As A Buy: MA, NTAP, JNJ
4:44 p.m. Sept. 22, 2014
- TheStreet.com
Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
3:59 p.m. Sept. 22, 2014
- Zacks.com
FDA authorizes Tekmira to provide TKM-Ebola
11:20 a.m. Sept. 22, 2014
- Seeking Alpha
"A Unique Period of Time," Revisited
9:48 a.m. Sept. 22, 2014
- GuruFocus.com
The 10-Point: Gerard Baker on Arming the Kurds, Crude by Rail, Deadly Medicine and More
7:07 a.m. Sept. 22, 2014
- The Wall Street Journal Interactive Edition
Gynecologists Resist FDA Over Popular Surgical Tool
11:59 p.m. Sept. 21, 2014
- The Wall Street Journal Interactive Edition
The Point Of No (Negative) Return
7:00 a.m. Sept. 21, 2014
- Seeking Alpha
Gilead's Zydelig Approved In EU; Imbruvica In Wings
11:17 a.m. Sept. 19, 2014
- Investors Business Daily
Stock Market News for September 19, 2014 - Market News
10:10 a.m. Sept. 19, 2014
- Zacks.com
Who Is Working on Ebola?
9:59 a.m. Sept. 19, 2014
- Barrons.com
Big Pharma Might Finally Be Over the Alzheimer’s Hump
5:32 a.m. Sept. 19, 2014
- InvestorPlace.com
Retired Investors Should Not Fear Recessions Or A Bad Market: Part 1
11:13 a.m. Sept. 18, 2014
- Seeking Alpha
Don't Own A Company If You Wouldn't Display It On Your Wall
11:11 p.m. Sept. 17, 2014
- Seeking Alpha
Actavis Is The Best Bet In The Drug Sector
9:35 a.m. Sept. 17, 2014
- Seeking Alpha
Why It's Time for Allergan Shareholders to Take Some Profits
1:09 p.m. Sept. 16, 2014
- TheStreet.com
Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien
9:05 a.m. Today9:05 a.m. Sept. 23, 2014
- PR Newswire - PRF
OxySure Systems Selected for USPTO / Smithsonian Innovation Expo
8:02 a.m. Today8:02 a.m. Sept. 23, 2014
- ACCESSWIRE
Twenty Employers to Attend Annual Life Science Hiring Event Next Week
9:00 a.m. Sept. 22, 2014
- PR Newswire - PRF
Mr. David Guerette Joins Matamec's Board of Directors
3:01 p.m. Sept. 19, 2014
- Marketwire
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma
9:15 a.m. Sept. 15, 2014
- PR Newswire - PRF
Sirius Solutions names Jessica Harris Director of Supply Chain Practice - Dallas/Ft. Worth Office
10:52 a.m. Sept. 12, 2014
- PR Newswire - PRF
Facial Care Market - Asia-Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019
8:48 p.m. Sept. 10, 2014
- PR Newswire - PRF
Transvaginal Mesh Lawsuit Latest Update News: J&J's Ethicon Loses another Mesh Trial
5:00 a.m. Sept. 9, 2014
- PR Newswire - PRF
Global Hepatitis C Market 2014-2018
9:58 p.m. Sept. 8, 2014
- PR Newswire - PRF
Jury Decides for Wexler Wallace LLP Client Against J&J Subsidiary: $3.27 Million
5:25 p.m. Sept. 5, 2014
- PR Newswire - PRF
We Are Mesh Survivors Applauds Verdict against Johnson and Johnson on
Pelvic Mesh: Jury Delivers $3.27 Million Verdict for Plaintiff Jo Huskey
in Johnson & Johnson Federal Trial on Pelvic Mesh Devices in West
Virginia
4:29 p.m. Sept. 5, 2014
- BusinessWire - BZX
Second Federal Ethicon Transvaginal Mesh Lawsuit Trial a $3.25 Million Win for Plaintiff, Bernstein Liebhard LLP Reports
3:47 p.m. Sept. 5, 2014
- PR Newswire - PRF
Upcoming Presentations, Technical Update, Study Results, and Marketing Authorization Application - Research Reports on Novartis, InterMune, Johnson & Johnson, Amgen and Merck
9:00 a.m. Sept. 5, 2014
- PR Newswire - PRF
Biotech Advancements in Innovative Cancer Therapy Reveal Developing Systemic Treatment Options - Company Receives Recommendation from World Health Organization for Lead Drug Candidate
8:15 a.m. Sept. 4, 2014
- PR Newswire - PRF
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
12:01 a.m. Sept. 4, 2014
- PR Newswire - PRF
Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health
12:00 a.m. Sept. 4, 2014
- Thomson Reuters ONE
Ironwood Appoints Two New Senior Executives to Support Continued
Growth as a Leader in Gastroenterology
5:00 p.m. Sept. 2, 2014
- BusinessWire - BZX
Acquisitions, Appointment, and Vaccine Recommendations - Research Reports on InterMune, Amgen, Johnson & Johnson, Merck and Medtronic
9:30 a.m. Aug. 28, 2014
- PR Newswire - PRF
IBM Watson Ushers in a New Era of Data-Driven Discoveries
12:01 a.m. Aug. 28, 2014
- PR Newswire - PRF
USIBC Concludes Successful Pharmaceutical Mission to India; Looks
Forward to Continued Dialogue and Collaboration with the Government of
India
11:46 a.m. Aug. 27, 2014
- BusinessWire - BZX
Dow industrials take flight, rally to uncharted territory
10:31 a.m. Sept. 19, 2014
- Michael Ashbaugh
7 reasons to be bullish on Microsoft
6:00 a.m. Sept. 18, 2014
- Jeff Reeves
5 pretty amazing facts about Alibaba
9:54 a.m. Sept. 15, 2014
- Tim Mullaney
Here’s what history says about the stock market in September
5:39 a.m. Sept. 2, 2014
- Mark Hulbert
This one stock sector can withstand all the ‘bubble’ talk
6:00 a.m. Aug. 21, 2014
- Jeff Reeves
Timing this market is guaranteed to make you a loser
1:02 p.m. Aug. 8, 2014
- Mark Hulbert
You don’t have to be a mega-mind to get this trade right
7:54 a.m. Aug. 6, 2014
- Jim Lowell
Mega caps with mega recommendations
7:54 a.m. Aug. 6, 2014
- Mark Hulbert
These eight health-care stocks could rise up to 75%
1:48 p.m. Aug. 5, 2014
- Philip van Doorn
J&J to call for voluntary return of morcellators
5:30 p.m. July 30, 2014
- MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’
1:14 p.m. July 22, 2014
- MarketWatch
Johnson & Johnson sets $5 billion share buyback
5:20 p.m. July 21, 2014
- Jim Jelter
Two rules of thumb for dumping your financial adviser
2:36 p.m. July 18, 2014
- Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap
3:04 p.m. July 15, 2014
- blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook
10:55 a.m. July 15, 2014
- blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger
10:40 a.m. July 15, 2014
- Angela Johnson
Newscast: NBA wants to double TV fees
9:59 a.m. July 15, 2014
- MarketWatch
Johnson & Johnson tops forecasts, boosts outlook
7:57 a.m. July 15, 2014
- MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade
7:51 a.m. July 15, 2014
- Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92
7:50 a.m. July 15, 2014
- William L. Watts
Spectrum to Buy P&G's European Pet Ops
46 min ago9:25 a.m. Sept. 23, 2014
- The Wall Street Journal Interactive Edition
Dividends Vs. Capital Appreciation: Wrong Question
10:14 p.m. Sept. 22, 2014
- Seeking Alpha
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
6:20 p.m. Sept. 22, 2014
- Zacks.com
Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
5:45 p.m. Sept. 22, 2014
- Zacks.com
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
4:45 p.m. Sept. 22, 2014
- Zacks.com
3 Stocks Reiterated As A Buy: MA, NTAP, JNJ
4:44 p.m. Sept. 22, 2014
- TheStreet.com
Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
3:59 p.m. Sept. 22, 2014
- Zacks.com
FDA authorizes Tekmira to provide TKM-Ebola
11:20 a.m. Sept. 22, 2014
- Seeking Alpha
"A Unique Period of Time," Revisited
9:48 a.m. Sept. 22, 2014
- GuruFocus.com
The 10-Point: Gerard Baker on Arming the Kurds, Crude by Rail, Deadly Medicine and More
7:07 a.m. Sept. 22, 2014
- The Wall Street Journal Interactive Edition
Gynecologists Resist FDA Over Popular Surgical Tool
11:59 p.m. Sept. 21, 2014
- The Wall Street Journal Interactive Edition
The Point Of No (Negative) Return
7:00 a.m. Sept. 21, 2014
- Seeking Alpha
Gilead's Zydelig Approved In EU; Imbruvica In Wings
11:17 a.m. Sept. 19, 2014
- Investors Business Daily
Stock Market News for September 19, 2014 - Market News
10:10 a.m. Sept. 19, 2014
- Zacks.com
Who Is Working on Ebola?
9:59 a.m. Sept. 19, 2014
- Barrons.com
Big Pharma Might Finally Be Over the Alzheimer’s Hump
5:32 a.m. Sept. 19, 2014
- InvestorPlace.com
Retired Investors Should Not Fear Recessions Or A Bad Market: Part 1
11:13 a.m. Sept. 18, 2014
- Seeking Alpha
Don't Own A Company If You Wouldn't Display It On Your Wall
11:11 p.m. Sept. 17, 2014
- Seeking Alpha
Actavis Is The Best Bet In The Drug Sector
9:35 a.m. Sept. 17, 2014
- Seeking Alpha
Why It's Time for Allergan Shareholders to Take Some Profits
1:09 p.m. Sept. 16, 2014
- TheStreet.com
Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien
9:05 a.m. Today9:05 a.m. Sept. 23, 2014
- PR Newswire - PRF
OxySure Systems Selected for USPTO / Smithsonian Innovation Expo
8:02 a.m. Today8:02 a.m. Sept. 23, 2014
- ACCESSWIRE
Twenty Employers to Attend Annual Life Science Hiring Event Next Week
9:00 a.m. Sept. 22, 2014
- PR Newswire - PRF
Mr. David Guerette Joins Matamec's Board of Directors
3:01 p.m. Sept. 19, 2014
- Marketwire
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma
9:15 a.m. Sept. 15, 2014
- PR Newswire - PRF
Sirius Solutions names Jessica Harris Director of Supply Chain Practice - Dallas/Ft. Worth Office
10:52 a.m. Sept. 12, 2014
- PR Newswire - PRF
Facial Care Market - Asia-Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019
8:48 p.m. Sept. 10, 2014
- PR Newswire - PRF
Transvaginal Mesh Lawsuit Latest Update News: J&J's Ethicon Loses another Mesh Trial
5:00 a.m. Sept. 9, 2014
- PR Newswire - PRF
Global Hepatitis C Market 2014-2018
9:58 p.m. Sept. 8, 2014
- PR Newswire - PRF
Jury Decides for Wexler Wallace LLP Client Against J&J Subsidiary: $3.27 Million
5:25 p.m. Sept. 5, 2014
- PR Newswire - PRF
We Are Mesh Survivors Applauds Verdict against Johnson and Johnson on
Pelvic Mesh: Jury Delivers $3.27 Million Verdict for Plaintiff Jo Huskey
in Johnson & Johnson Federal Trial on Pelvic Mesh Devices in West
Virginia
4:29 p.m. Sept. 5, 2014
- BusinessWire - BZX
Second Federal Ethicon Transvaginal Mesh Lawsuit Trial a $3.25 Million Win for Plaintiff, Bernstein Liebhard LLP Reports
3:47 p.m. Sept. 5, 2014
- PR Newswire - PRF
Upcoming Presentations, Technical Update, Study Results, and Marketing Authorization Application - Research Reports on Novartis, InterMune, Johnson & Johnson, Amgen and Merck
9:00 a.m. Sept. 5, 2014
- PR Newswire - PRF
Biotech Advancements in Innovative Cancer Therapy Reveal Developing Systemic Treatment Options - Company Receives Recommendation from World Health Organization for Lead Drug Candidate
8:15 a.m. Sept. 4, 2014
- PR Newswire - PRF
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
12:01 a.m. Sept. 4, 2014
- PR Newswire - PRF
Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health
12:00 a.m. Sept. 4, 2014
- Thomson Reuters ONE
Ironwood Appoints Two New Senior Executives to Support Continued
Growth as a Leader in Gastroenterology
5:00 p.m. Sept. 2, 2014
- BusinessWire - BZX
Acquisitions, Appointment, and Vaccine Recommendations - Research Reports on InterMune, Amgen, Johnson & Johnson, Merck and Medtronic
9:30 a.m. Aug. 28, 2014
- PR Newswire - PRF
IBM Watson Ushers in a New Era of Data-Driven Discoveries
12:01 a.m. Aug. 28, 2014
- PR Newswire - PRF
USIBC Concludes Successful Pharmaceutical Mission to India; Looks
Forward to Continued Dialogue and Collaboration with the Government of
India
11:46 a.m. Aug. 27, 2014
- BusinessWire - BZX
(0)
(0)